Efficient generation of nonhuman primate induced pluripotent stem cells.

Publication Type:

Journal Article


Stem cells and development, Volume 20, Issue 5, p.795-807 (2011)


2011, Animals, Cell Differentiation, Cell Line, Center-Authored Paper, Clinical Research Division, Comparative Medicine Core Facility, Experimental Histopathology Core Facility, Female, Fibroblasts, Flow Cytometry Core Facility, Gammaretrovirus, Genetic Vectors, Humans, Induced Pluripotent Stem Cells, Kruppel-Like Transcription Factors, Macaca nemestrina, Male, MICE, Microarray Analysis, Nuclear Reprogramming, Octamer Transcription Factor-3, Proto-Oncogene Proteins c-myc, Regenerative Medicine, Reverse Transcriptase Polymerase Chain Reaction, RISK, Shared Resources, SOXB1 Transcription Factors, Transfection


Induced pluripotent stem (iPS) cells have great potential for regenerative medicine and gene therapy. Thus far, iPS cells have typically been generated using integrating viral vectors expressing various reprogramming transcription factors; nonintegrating methods have been less effective and efficient. Because there is a significant risk of malignant transformation and cancer involved with the use of iPS cells, careful evaluation of transplanted iPS cells will be necessary in small and large animal studies before clinical application. Here, we have generated and characterized nonhuman primate iPS cells with the goal of evaluating iPS cell transplantation in a clinically relevant large animal model. We developed stable Phoenix-RD114-based packaging cell lines that produce OCT4, SOX2, c-MYC, and KLF4 (OSCK) expressing gammaretroviral vectors. Using these vectors in combination with small molecules, we were able to efficiently and reproducibly generate nonhuman primate iPS cells from pigtailed macaques (Macaca nemestrina). The established nonhuman primate iPS cells exhibited pluripotency and extensive self-renewal capacity. The facile and reproducible generation of nonhuman primate iPS cells using defined producer cells as a source of individual reprogramming factors should provide an important resource to optimize and evaluate iPS cell technology for studies involving stem cell biology and regenerative medicine.